Enzyme kinetic properties of human recombinant arylamine n-acetyltransferase 2 allotypic variants expressed in Escherichia coli
Authors:
- Jairam R. PalamandaJPJairam R. Palamanda
- Jashvant D. UnadkatJUJashvant D. Unadkat
- Edith SimESEdith Sim
- 1 August 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (5) , 697-703
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogensNature, 1994
- Chromosomal localization of human genes for arylamine N-acetyltransferaseBiochemical Journal, 1994
- Structural Heterogeneity of Caucasian N-Acetyltransferase at the NAT1 Gene LocusArchives of Biochemistry and Biophysics, 1993
- SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-AmericansCarcinogenesis, 1993
- The pharmacogenetics of chemical carcinogenesisPharmacogenetics, 1992
- Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variantsPharmacogenetics, 1992
- High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosusGene, 1991
- Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidencePharmacogenetics, 1991
- N-acetyltransferase polymorphismBiochemical Pharmacology, 1991
- [6] Use of T7 RNA polymerase to direct expression of cloned genes1990